United Therapeutics (UTHR) Tops Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $547.15 --0%
EPS Growth %: +11.9%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
PKE, LNN, More
EPS Growth %: +11.9%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $2.55, $0.24 better than the analyst estimate of $2.31. Revenue for the quarter came in at $347.2 million versus the consensus estimate of $360.41 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Trump's $1.2 billion D.C. spending spree fans fiscal fears as yields surge
- Liberty Media Corp-Liberty Formula One (FWONA) PT Raised to $120 at Citizens
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
